Literature DB >> 9877275

Bone marrow transplantation as treatment for X-linked immunodeficiency with hyper-IgM.

P Bordigoni1, B Auburtin, A S Carret, A Schuhmacher, J C Humbert, F Le Deist, D Sommelet.   

Abstract

We report a 10-year-old boy with a severe form of immunodeficiency with hyper-IgM who underwent successful bone marrow transplantation with his HLA-matched sister as donor. Busulfan (20 mg/kg) and cyclophosphamide (200 mg/kg) were used as conditioning. The post-transplant course was uneventful. He is alive 25 months later with full hematological and immunological reconstitution.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9877275     DOI： 10.1038/sj.bmt.1701497

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


  5 in total

Review 1.  Recent advances in transplantation for primary immune deficiency diseases: a comprehensive review.

Authors:  M Teresa de la Morena; Robert P Nelson
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

2.  Bone marrow transplantation for CD40 ligand deficiency: a single centre experience.

Authors:  K Khawaja; A R Gennery; T J Flood; M Abinun; A J Cant
Journal:  Arch Dis Child       Date:  2001-06       Impact factor: 3.791

3.  Long-term outcomes of 176 patients with X-linked hyper-IgM syndrome treated with or without hematopoietic cell transplantation.

Authors:  M Teresa de la Morena; David Leonard; Troy R Torgerson; Otavio Cabral-Marques; Mary Slatter; Asghar Aghamohammadi; Sharat Chandra; Luis Murguia-Favela; Francisco A Bonilla; Maria Kanariou; Rongras Damrongwatanasuk; Caroline Y Kuo; Christopher C Dvorak; Isabelle Meyts; Karin Chen; Lisa Kobrynski; Neena Kapoor; Darko Richter; Daniela DiGiovanni; Fatima Dhalla; Evangelia Farmaki; Carsten Speckmann; Teresa Español; Anna Shcherbina; Imelda Celine Hanson; Jiri Litzman; John M Routes; Melanie Wong; Ramsay Fuleihan; Suranjith L Seneviratne; Trudy N Small; Ales Janda; Liliana Bezrodnik; Reinhard Seger; Andrea Gomez Raccio; J David M Edgar; Janet Chou; Jordan K Abbott; Joris van Montfrans; Luis Ignacio González-Granado; Nancy Bunin; Necil Kutukculer; Paul Gray; Gisela Seminario; Srdjan Pasic; Victor Aquino; Christian Wysocki; Hassan Abolhassani; Morna Dorsey; Charlotte Cunningham-Rundles; Alan P Knutsen; John Sleasman; Beatriz Tavares Costa Carvalho; Antonio Condino-Neto; Eyal Grunebaum; Helen Chapel; Hans D Ochs; Alexandra Filipovich; Mort Cowan; Andrew Gennery; Andrew Cant; Luigi D Notarangelo; Chaim M Roifman
Journal:  J Allergy Clin Immunol       Date:  2016-09-30       Impact factor: 10.793

4.  CD154-CD40 interactions in the control of murine B cell hematopoiesis.

Authors:  Jennifer Carlring; Hala M Altaher; Susan Clark; Xi Chen; Sarah L Latimer; Tracey Jenner; Anne-Marie Buckle; Andrew W Heath
Journal:  J Leukoc Biol       Date:  2011-02-17       Impact factor: 4.962

Review 5.  ICON: the early diagnosis of congenital immunodeficiencies.

Authors:  John Routes; Mario Abinun; Waleed Al-Herz; Jacinta Bustamante; Antonio Condino-Neto; Maria Teresa De La Morena; Amos Etzioni; Eleonora Gambineri; Elie Haddad; Lisa Kobrynski; Francoise Le Deist; Shigeaki Nonoyama; Joao Bosco Oliveira; Elena Perez; Capucine Picard; Nima Rezaei; John Sleasman; Kathleen E Sullivan; Troy Torgerson
Journal:  J Clin Immunol       Date:  2014-03-12       Impact factor: 8.542
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.